Fasting-Mimicking Diet for Inflammatory Bowel Disease-Related Depression
Trial Summary
What is the purpose of this trial?
Inflammatory bowel disease (IBD) is a chronic illness characterized by inflammation of the intestine. Many individuals with IBD suffer from depressive symptoms and anxiety which can lead to a decreased quality of life, poor treatment compliance, and higher morbidity and mortality. The object of this clinical trial is to investigate the effects of a fasting mimicking diet in IBD patients who are suffering with symptoms of depression. Participants will carry out 3 cycles of a 5-day period of a plant-based low caloric diet or a plant-based caloric sufficient diet following by 3 weeks of eating normally. Effects of the dietary intervention on microbes in the gut, immune and metabolic function, and depressive symptoms will be measured. The overall goal is to develop a safe and effective treatment to improve mental health in patients with IBD by targeting the gut microbiome through dietary interventions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the fasting-mimicking diet treatment for inflammatory bowel disease-related depression?
How is the fasting-mimicking diet treatment different from other treatments for inflammatory bowel disease-related depression?
The fasting-mimicking diet is unique because it involves a plant-based, low-calorie approach that mimics the effects of fasting, potentially offering benefits for inflammatory bowel disease-related depression by altering gut microbiota and reducing inflammation, unlike traditional diets that may not have these specific effects.16789
Research Team
Karen Madsen, PhD
Principal Investigator
University of Alberta
Eligibility Criteria
This trial is for adults aged 18-65 with Crohn's disease or ulcerative colitis in remission, who are experiencing mild to moderate depression. They must not be underweight, malnourished, have a severe illness like AIDS or cancer, be pregnant or breastfeeding, have had certain gastrointestinal surgeries, suffer from diabetes or celiac disease, nor have a history of psychotic disorders.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants are followed for baseline assessment before starting the diet intervention
Treatment
Participants consume a plant-based fasting-mimicking diet or a caloric-sufficient diet for 5 days once a month for 3 months
Follow-up
Participants are monitored for changes in depressive symptoms, gut microbiome, and other health markers
Treatment Details
Interventions
- Plant-based fasting-mimicking diet (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Bill Flanagan
University of Alberta
Chief Executive Officer since 2020
LLB from University of Toronto, LLM from Columbia University
Dr. Verna Yiu
University of Alberta
Chief Medical Officer since 2012
MD from University of Alberta, Fellowship in Pediatric Nephrology at Harvard University
W. Garfield Weston Foundation
Collaborator